These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 11434173)
21. National surveillance of dialysis-associated diseases in the United States, 2001. Tokars JI; Finelli L; Alter MJ; Arduino MJ Semin Dial; 2004; 17(4):310-9. PubMed ID: 15250925 [TBL] [Abstract][Full Text] [Related]
22. Outcome of hepatitis B and C virus infection on graft function after renal transplantation. Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299 [TBL] [Abstract][Full Text] [Related]
23. [Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study]. Fabrizi F; Bisegna S; Mangano S; Alongi G; Colucci P; Finazzi S; De Vecchi AF; Ponticelli C G Ital Nefrol; 2002; 19(2):149-54. PubMed ID: 12195413 [TBL] [Abstract][Full Text] [Related]
24. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients. Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901 [TBL] [Abstract][Full Text] [Related]
25. Occult hepatitis B virus infection in hemodialysis patients with chronic HCV infection. Siagris D; Christofidou M; Triga K; Pagoni N; Theocharis GJ; Goumenos D; Lekkou A; Thomopoulos K; Tsamandas AC; Vlachojannis J; Labropoulou-Karatza C J Nephrol; 2006; 19(3):327-33. PubMed ID: 16874693 [TBL] [Abstract][Full Text] [Related]
26. [HBV and HCV infections among selected group of patients and staff members in the prospective study]. Urbanowicz W Przegl Epidemiol; 1996; 50(4):365-70. PubMed ID: 9132791 [TBL] [Abstract][Full Text] [Related]
27. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation. Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430 [TBL] [Abstract][Full Text] [Related]
28. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies. Said ZN; El-Sayed MH; El-Bishbishi IA; El-Fouhil DF; Abdel-Rheem SE; El-Abedin MZ; Salama II Liver Int; 2009 Apr; 29(4):518-24. PubMed ID: 19192168 [TBL] [Abstract][Full Text] [Related]
29. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B. Moutinho RS; Perez RM; Medina-Pestana JO; Figueiredo MS; Koide S; Alberto FL; Silva AE; Ferraz ML J Med Virol; 2006 Oct; 78(10):1284-8. PubMed ID: 16927290 [TBL] [Abstract][Full Text] [Related]
30. Molecular epidemiology of hepatitis B, C, D and E viruses among children in Moscow, Russia. Abe K; Hayakawa E; Sminov AV; Rossina AL; Ding X; Huy TT; Sata T; Uchaikin VF J Clin Virol; 2004 May; 30(1):57-61. PubMed ID: 15072755 [TBL] [Abstract][Full Text] [Related]
31. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Johnson DW; Dent H; Yao Q; Tranaeus A; Huang CC; Han DS; Jha V; Wang T; Kawaguchi Y; Qian J Nephrol Dial Transplant; 2009 May; 24(5):1598-603. PubMed ID: 19096083 [TBL] [Abstract][Full Text] [Related]
32. Improved hepatitis B vaccination rates in ESRD patients in California. Brown J; Peters V Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S95-9. PubMed ID: 11053594 [TBL] [Abstract][Full Text] [Related]
33. [Clinical study of lamivudine and interferon combinate administration to inhibit hepatitis B virus replication]. Song JW; Zhang G; Lin JG; Tang WX; Lin JS Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):593-6. PubMed ID: 15504288 [TBL] [Abstract][Full Text] [Related]
34. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha. Kansu A; Kuloğlu Z; Demirçeken F; Girgin N Turk J Gastroenterol; 2004 Dec; 15(4):213-8. PubMed ID: 16249973 [TBL] [Abstract][Full Text] [Related]
35. Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children. Rouet F; Chaix ML; Inwoley A; Anaky MF; Fassinou P; Kpozehouen A; Rouzioux C; Blanche S; Msellati P; Clin Infect Dis; 2008 Feb; 46(3):361-6. PubMed ID: 18171303 [TBL] [Abstract][Full Text] [Related]
36. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B. Lo CM; Liu CL; Chan SC; Lau GK; Fan ST J Hepatol; 2005 Aug; 43(2):283-7. PubMed ID: 15964658 [TBL] [Abstract][Full Text] [Related]
37. Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia. Almawi WY; Qadi AA; Tamim H; Ameen G; Bu-Ali A; Arrayid S; Abou Jaoude MM Transplant Proc; 2004; 36(6):1824-6. PubMed ID: 15350487 [TBL] [Abstract][Full Text] [Related]
38. Relationship of hepatitis B or C virus prevalences, risk factors, and outcomes in renal transplant recipients: analysis of German data. Kliem V; Burg M; Haller H; Suwelack B; Abendroth D; Fritsche L; Fornara P; Pietruck F; Frei U; Donauer J; Lison AE; Michel U Transplant Proc; 2008 May; 40(4):909-14. PubMed ID: 18555076 [TBL] [Abstract][Full Text] [Related]
39. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases. Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833 [TBL] [Abstract][Full Text] [Related]